Stocktoria

PLIANT THERAPEUTICS, INC. PLRX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-06-03 · LEI

PLIANT THERAPEUTICS, INC. statistics & valuation

Market cap$70.6M
P / B0.4×
Return on equity-82.4%
Net cash$45.4M
Enterprise value USD$25.1M
Return on capital-74.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-2.20% -99.60% -1288.10% -1313.40% -11654.70% 2019202020212022202320242025
Return on equity (%)
-14.70% -48.90% -39.40% -34.10% -69.20% -82.40% 2019202020212022202320242025
Shares outstanding
1.8M 35.6M 36.1M 48.9M 59.9M 60.9M 61.4M 2019202020212022202320242025
Net debt ($)
-$51.7M -$23.8M -$53.2M -$41.0M -$45.4M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-0.50% -14.10% -44.00% -35.20% -31.50% -53.00% -66.30% 2019202020212022202320242025
Free cash flow margin (%)
-6.50% -92.80% -1022.10% -995.30% -7422.90% 2019202020212022202320242025
Debt / equity (×)
0.00× 0.03× 0.02× 0.10× 0.00× 2019202020212022202320242025
EPS ($)
-$4.22 -$1.95 -$2.71 -$2.94 -$2.75 -$3.47 -$2.43 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin——-11654.7%-1313.4%-1288.1%-99.6%-2.2%
Net margin——-10211.1%-1273.3%-1284.5%-99.3%-1.1%
FCF margin——-7422.9%-995.3%-1022.1%-92.8%-6.5%
Return on assets-66.3%-53.0%-31.5%-35.2%-44.0%-14.1%-0.5%
Return on equity-82.4%-69.2%-34.1%-39.4%-48.9%-14.7%0.8%
Debt / equity0.00×0.10×0.02×0.03×0.00×——
Current ratio12.0010.9117.7214.2312.4425.0713.69

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.